Immunotherapy could be used to treat depression among patients who have not responded to conventional antidepressants, according to the results of an early clinical trial...
Showing posts with label immunotherapy. Show all posts
Showing posts with label immunotherapy. Show all posts
Thursday, May 21, 2026
Saturday, November 10, 2018
New immunotherapy technique can specifically target tumor cells, UCI study reports | UCI News | UCI
“Lab on a chip” technology can be used to create individualized treatments for cancer...
https://news.uci.edu/2018/11/06/new-immunotherapy-technique-can-specifically-target-tumor-cells-uci-study-reports/
https://news.uci.edu/2018/11/06/new-immunotherapy-technique-can-specifically-target-tumor-cells-uci-study-reports/
Wednesday, October 25, 2017
A cancer treatment that's part of 'a big new field of medicine' just got approved -- Business Insider
The FDA just approved another revolutionary cancer treatment. The treatment, called Yescarta, treats a type of blood cancer called aggressive B-cell non-Hodgkin lymphoma. The highly personalized cancer treatment called CAR T-cell therapy (CAR is short for chimeric antigen receptor) is made by Kite Pharma, a company that in August was acquired by biotech giant Gilead Sciences. ....
http://www.businessinsider.com/car-t-cell-therapy-approval-gilead-kite-2017-10
http://www.businessinsider.com/car-t-cell-therapy-approval-gilead-kite-2017-10
Friday, June 17, 2016
A Scientist's Dream Fulfilled: Harnessing The Immune System To Fight Cancer
"It used to be there were three basic treatment options for cancer — surgery, radiation and chemotherapy — or some combination of those three. It's fair to say there's now a fourth option."...
http://www.npr.org/sections/health-shots/2016/06/09/480435066/a-scientists-dream-fulfilled-harnessing-the-immune-system-to-fight-cancer?ft=nprml&f=1001
http://www.npr.org/sections/health-shots/2016/06/09/480435066/a-scientists-dream-fulfilled-harnessing-the-immune-system-to-fight-cancer?ft=nprml&f=1001
Subscribe to:
Posts (Atom)

